Phase 3, open-label, multicenter safety study of oral edaravone in patients with amyotrophic lateral sclerosis (MT-1186-A01): 48-week resultsAngela Genge,Gary L. Pattee,Gen Sobue,Philippe Couratier,Daniel Selness,Sachin Bidani,Manabu Hirai,Alejandro Salah,Stephen AppleANNALS OF NEUROLOGY(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要